🇺🇸 FDA
Pipeline program

Ramosetron

060-CL-500

Approved small_molecule completed

Quick answer

Ramosetron for Irritable Bowel Syndrome is a Approved program (small_molecule) at Astellas Pharma Inc with 1 ClinicalTrials.gov record(s).

Program details

Company
Astellas Pharma Inc
Indication
Irritable Bowel Syndrome
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials